SRPT Down Near 9-Year Low, CSCO Upgrade, ROKU Using AMZN Ads скачать в хорошем качестве

SRPT Down Near 9-Year Low, CSCO Upgrade, ROKU Using AMZN Ads

Sarepta Therapeutics (SRPT) sold off more than 40% after suspending its Elevidys Duchenne muscular dystrophy drug, which was linked to two fatal liver failure cases. Diane King Hall break takes a closer look into the report. She later turns to an upgrade Cisco (CSCO) got from Deutsche Bank on A.I. optimism, along with news on Roku Inc. (ROKU) integrating Amazon (AMZN) ads with its platform. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-... Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-... Watch on Sling - https://watch.sling.com/1/asset/19192... Watch on Vizio - https://www.vizio.com/en/watchfreeplu... Watch on DistroTV - https://www.distro.tv/live/schwab-net... Follow us on X –   / schwabnetwork   Follow us on Facebook –   / schwabnetwork   Follow us on LinkedIn -   / schwab-network   About Schwab Network - https://schwabnetwork.com/about #srpt #csco #roku #economy #finance #investing #marketnews #stock #stockmarket #trading #investing #schwabnetwork #sarepta #therapeutics #cisco #amzn #amazon